1	planned administration/ administration of a vaccine not foresee by the study protocol within 30 day prior to until 42 day after the study vaccine dose with the exception of inactivate vaccine such a pneumococcal haemophilus influenzae type b conjugate vaccine inactivate influenza hepatitis a or b vaccine|vaccine[138,145]|||||||30 day[93,99]|||11094|11094|vaccine
1	planned administration/ administration of a vaccine not foresee by the study protocol within 30 day prior to until 42 day after the study vaccine dose with the exception of inactivate vaccine such a pneumococcal haemophilus influenzae type b conjugate vaccine inactivate influenza hepatitis a or b vaccine|vaccine[184,191]||||||||||11094|11094|vaccine
1	planned administration/ administration of a vaccine not foresee by the study protocol within 30 day prior to until 42 day after the study vaccine dose with the exception of inactivate vaccine such a pneumococcal haemophilus influenzae type b conjugate vaccine inactivate influenza hepatitis a or b vaccine|pneumococcal[199,211]|||||||||C0358314|106467|106467|pneumococcal vaccine
1	planned administration/ administration of a vaccine not foresee by the study protocol within 30 day prior to until 42 day after the study vaccine dose with the exception of inactivate vaccine such a pneumococcal haemophilus influenzae type b conjugate vaccine inactivate influenza hepatitis a or b vaccine|haemophilus influenzae type b[212,241]|||||||||C0121772|50937|50937|haemophilus b
1	planned administration/ administration of a vaccine not foresee by the study protocol within 30 day prior to until 42 day after the study vaccine dose with the exception of inactivate vaccine such a pneumococcal haemophilus influenzae type b conjugate vaccine inactivate influenza hepatitis a or b vaccine|conjugate vaccine[242,259]||||||||||90039|90039|conjugate vaccine
1	planned administration/ administration of a vaccine not foresee by the study protocol within 30 day prior to until 42 day after the study vaccine dose with the exception of inactivate vaccine such a pneumococcal haemophilus influenzae type b conjugate vaccine inactivate influenza hepatitis a or b vaccine|vaccine[298,305]||||||||||11094|11094|vaccine
2	or diphtheria/tetanus-containing vaccine which can be administer up to eight day before the study vaccine dose|vaccine[339,346]|||||||eight day[377,386]|||11094|11094|vaccine
2	or diphtheria/tetanus-containing vaccine which can be administer up to eight day before the study vaccine dose|vaccine[404,411]||||||||||11094|11094|vaccine
